| Literature DB >> 30214963 |
Christos Moschovos1, Apostolia Ghika2, Andreas Kyrozis2.
Abstract
OBJECTIVE: The utility of Dermatomal Somatosensory Evoked Potentials (DSEPs) in the diagnostic workup of suspected cervical monoradiculopathy has been limited by significant overlap between measurements obtained from affected versus unaffected roots. In a case-control study, we explored whether, under certain conditions, asymmetry in DSEP parameters may offer significant help in the diagnosis of monoradiculopathy.Entities:
Keywords: DSEP; DSEP, Dermatomal Somatosensory Evoked Potentials; Dermatomal; Evoked potential; P/N13′; P/N13′, negative peak at 13 ms; Radiculopathy; Somatosensory
Year: 2016 PMID: 30214963 PMCID: PMC6123873 DOI: 10.1016/j.cnp.2016.10.002
Source DB: PubMed Journal: Clin Neurophysiol Pract ISSN: 2467-981X
Characteristics of indvidual subjects.
| id | Group | Sex | Age | rootLevel | AMPasym_hi | AMPsym_lo | AMPratio | LATasym_hi | LATsym_lo |
|---|---|---|---|---|---|---|---|---|---|
| 11 | Persist | M | 45 | C6 | 0.46 | 0.16 | 0.34 | 18.5 | 18.7 |
| 12 | Persist | M | 47 | C7 | 0.49 | 0.13 | 0.28 | 15.4 | 16.3 |
| 13 | Persist | F | 43 | C6 | 0.88 | 0.32 | 0.37 | 16.5 | 17.4 |
| 14 | Persist | F | 55 | C6 | 0.56 | 0.05 | 0.09 | 18.2 | 19.0 |
| 15 | Persist | F | 42 | C6 | 0.40 | 0.20 | 0.50 | 17.1 | 17.3 |
| 16 | Persist | M | 41 | C8 | 0.58 | 0.21 | 0.37 | 16.9 | 19.7 |
| 17 | Persist | F | 33 | C6 | 0.75 | 0.22 | 0.30 | 16.6 | 17.3 |
| 18 | Persist | F | 37 | C6 | 0.65 | 0.00 | 0.00 | 16.9 | |
| 19 | Persist | F | 37 | C7 | 0.75 | 0.00 | 0.00 | 17.5 | |
| 20 | Persist | F | 36 | C6 | 0.55 | 0.00 | 0.00 | 17.2 | |
| 21 | Interm | M | 46 | C6 | 0.91 | 0.57 | 0.62 | 17.1 | 18.3 |
| 22 | Interm | F | 33 | C7 | 0.67 | 0.42 | 0.63 | 16.4 | 16.1 |
| 23 | Interm | F | 49 | C6 | 0.66 | 0.64 | 0.97 | 21.6 | 20.2 |
| 24 | Interm | F | 31 | C6 | 0.61 | 0.65 | 1.07 | 17.1 | 17.0 |
| 25 | Interm | F | 46 | C7 | 0.71 | 0.93 | 1.30 | 16.4 | 15.4 |
| 26 | Interm | M | 55 | C6 | 0.60 | 0.54 | 0.91 | 18.4 | 19.0 |
| 27 | Interm | F | 35 | C6 | 0.96 | 0.79 | 0.82 | 16.7 | 15.6 |
| 31 | AsymYng | M | 31 | C6 | 0.83 | 0.67 | 0.80 | 16.1 | 16.6 |
| 32 | AsymYng | M | 37 | C6 | 1.04 | 0.97 | 0.93 | 18.6 | 18.7 |
| 33 | AsymYng | F | 54 | C6 | 0.96 | 0.79 | 0.82 | 17.5 | 18.0 |
| 34 | AsymYng | M | 52 | C6 | 1.20 | 1.02 | 0.85 | 16.9 | 17.3 |
| 35 | AsymYng | F | 36 | C6 | 0.90 | 0.80 | 0.89 | 15.0 | 15.4 |
| 36 | AsymYng | F | 34 | C6 | 1.25 | 1.19 | 0.95 | 15.4 | 15.8 |
| 37 | AsymYng | F | 31 | C6 | 0.95 | 0.89 | 0.93 | 15.4 | 16.0 |
| 38 | AsymYng | F | 40 | C6 | 0.61 | 0.59 | 0.97 | 16.2 | 16.6 |
| 41 | AsymOld | M | 65 | C6 | 0.29 | 0.00 | 0.00 | 18.7 | |
| 42 | AsymOld | F | 57 | C6 | 0.75 | 0.40 | 0.53 | 17.5 | 17.3 |
| 43 | AsymOld | M | 77 | C6 | 0.75 | 0.47 | 0.62 | 16.2 | 17.1 |
| 44 | AsymOld | F | 66 | C6 | 0.40 | 0.20 | 0.50 | 16.5 | 15.4 |
| 45 | AsymOld | F | 71 | C6 | 0.44 | 0.00 | 0.00 | 15.6 | |
| 46 | AsymOld | F | 58 | C6 | 1.01 | 0.80 | 0.79 | 17.8 | 15.9 |
| 47 | AsymOld | M | 57 | C6 | 0.00 | 0.00 | |||
| 48 | AsymOld | M | 68 | C6 | 0.00 | 0.00 |
PS: persistent symptom of unilateral numbness.
IS: intermittent symptom of unilateral numbness.
AsymYng: asymptomatic, age-matched (31–54 years) subjects.
AsymOld: asymptomatic, older (57–77 years) subjects.
AMPasym_hi: P/N13′ DSEP amplitude of asymptomatic side (in patients) or of higher amplitude side (in asymptomatic controls).
AMPsym_lo: P/N13′ DSEP amplitude of symptomatic side (in patients) or of lower amplitude side (in asymptomatic controls).
AMPratio: P/N13′ DSEP amplitude ratio of symptomatic/asymptomatic side (in patients) or of lower/higher amplitude side (in asymptomatic controls).
LATasym_hi: P/N13′ DSEP latency of asymptomatic side (in patients) or of higher amplitude side (in asymptomatic controls).
LATsym_lo: P/N13′ DSEP latency of symptomatic side (in patients) or of lower amplitude side (in asymptomatic controls).
Characteristics of the four population groups: number of subjects in each group (n), ages, latencies and amplitudes of N13′ Dermatomal Somatosensory Evoked Potentials (DSEPs).
| Age (years) | Latency (ms) | Amplitude (μV) | Amplitude ratio | |||
|---|---|---|---|---|---|---|
| Mean (range) | Mean ± sem (range) | Mean ± SEM (range) | Mean ± SEM (range) | |||
| Young asymptomatic | 8 | 39.4 (31–54) | Both sides ( | 16.6 ± 0.3 | 0.92 ± 0.05 | 0.89 ± 0.02 |
| (15.0–18.7) | (0.59–1.25) | |||||
| Young – intermittent unilateral symptoms (IS) | 7 | 42.1 (31–55) | Symptomatic side | 17.4 ± 0.7 | 0.65 ± 0.06 | 0.90 ± 0.09 |
| (15.4–20.2) | (0.42–0.93) | |||||
| Asymptomatic side | 17.6 ± 0.7 | 0.73 ± 0.06 | ||||
| (16.4–21.6) | (0.60–0.96) | |||||
| Young – persistent unilateral symptoms (PS) | 10 | 41.6 (33–45) | Symptomatic side | 17.9 ± 0.4 | 0.13 ± 0.04 | 0.22 ± 0.06 |
| (16.3–19.7) | (0.00–0.32) | |||||
| Asymptomatic side | 17.1 ± 0.3 | 0.61 ± 0.05 | ||||
| (15.4–18.5) | (0.40–0.88) | |||||
| >55 years asymptomatic | 8 | 64.9 (57–77) | Both sides ( | 16.8 ± 0.3 | 0.34 ± 0.08 | 0.41 ± 0.14 |
| (15.4–18.7) | (0.00–1.01) |
Ratio of lower to higher amplitude.
Ratio of amplitude at symptomatic to amplitude at asymptomatic side.
Fig. A1Choice of reference electrode. Simultaneous recording of N13′ complex in a normal subject using a non-cephalic (NC, contralateral shoulder) reference electrode (upper three traces, where the third trace stands for the average of the first two) and the Fpz’ as a reference electrode (bottom three traces). The signal of interest can be more prominently seen in the second case. We preferred a cephalic reference electrode (although it contaminates signal with P13/P14 far field potential) because a non-cephalic one records the desired signal with a significantly lower amplitude. Furthermore, the vast majority of studies using DSEPs have been conducted using a cephalic reference electrode.
Fig. A2Choice of active electrode site. Simultaneous recording of P/N13′ complex in a normal subject using the derivation more commonly used with the active electrode over C6 (upper three traces, the third trace being the average of the first two) and the derivation employed in the present study (bottom three traces) where the active electrode is placed over C2. With this montage P/N13′ complex potential has a somewhat higher amplitude. When positioning the active electrode at C2 level, P/N13′ had a somewhat higher amplitude in previous studies as well (Sonoo et al., 1990), (Kwast-Rabben et al., 2008). See also recommendations for Median nerve DSEPs in textbook by Dumitru (2000), pp. 388–389.
Fig. A3The effect of the narrow band filter (low-pass filter at 200 Hz) on N13′ complex morphology. Simultaneous recording of N13′ complex in a young asymptomatic subject using the more frequently applied filter band of 0.5–2000 Hz (a) and the more restricted filter band applied in the present study (0.5–200 Hz) (b). In each panel (a, b) the bottom third trace represents the average of the above two traces (2 × 500 stimuli). With the 200 Hz low-pass filter, there appears to be less contamination by high frequency noise. A disadvantage of the narrow filter range is an artifactual phase shift of N13′ complex, resulting in a longer latency measurement.
Fig. 1Example of typical Dermatomal Somatosensory Evoked Potentials (DSEP) recording in a normal subject. Stimulation of the right thumb. Recording at level of the second cervical vertebra (C2). Filter band at 0.5–200 Hz. Each of the two upper traces represents the average response to a train of 500 stimuli. The bottom third trace represents the average of the above two traces. The prominent upward (negative) peak is the P/N13′ complex.
Fig. 2Histogram showing P/N13′ amplitude (mean ± SEM) in every side and in every group studied. Patient groups: Intermittent unilateral sensory symptoms (ages 31–55, n = 7). Persistent unilateral sensory symptoms (ages 33–55, n = 10). A: asymptomatic side, S: symptomatic side. Asymptomatic groups: Age-matched (ages 31–54, n = 8). Older (ages 57–77, n = 8). Hi: Side with higher amplitude, Lo: Side with lower amplitude.
Fig. 3Scatterplot showing ratios of P/N13′ amplitudes between sides in every subject of the three age-matched groups. In the intermittent (n = 7) and the persistent (n = 10) unilateral sensory symptom groups, ratio = symptomatic divided by asymptomatic side. In the asymptomatic age-matched group (n = 8), ratio = lower amplitude divided by higher amplitude. Ratios of 0.5 or less were observed in all patients with persistent symptoms.